Showing 201 - 220 results of 675 for search '(( third ((((nn decrease) OR (larger decrease))) OR (a decrease)) ) OR ( cloud data decrease ))', query time: 0.56s Refine Results
  1. 201
  2. 202
  3. 203

    Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…Outpatient visit frequency also significantly declined from 11.5 ± 4.3 visits in the year before surgery to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g004" target="_blank">Fig 4</a>).…”
  4. 204

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  5. 205

    Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…These values significantly decreased in the first postoperative year to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0, and 3.1 ± 2.8; in the second year to 2.1 ± 2.8, 0.4 ± 1.0, 0.0, 0.1 ± 0.3, and 2.6 ± 2.8; and in the third year to 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 (Kruskal–Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g007" target="_blank">Fig 7</a>). …”
  6. 206

    Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…These significantly decreased to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0.0, and 3.1 ± 2.8 in the first year; 2.1 ± 2.8, 0.4 ± 1.0, 0, 0.1 ± 0.3, and 2.6 ± 2.8 in the second year; and 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 in the third year (Kruskal–Wallis test, p < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …”
  7. 207
  8. 208

    Participant recruitment process flowchart. by Azam Ildarabadi (20565175)

    Published 2025
    “…The risk of HDL-C appeared to decrease in the third quartile of pepper consumption (HR: 1, 0.97, 0.87, 1.03, P-trend = 0.008).…”
  9. 209

    Participant recruitment process flowchart. by Azam Ildarabadi (20565175)

    Published 2025
    “…The risk of HDL-C appeared to decrease in the third quartile of pepper consumption (HR: 1, 0.97, 0.87, 1.03, P-trend = 0.008).…”
  10. 210

    Participants enrollment. by Chikondi Maluwa (20660522)

    Published 2025
    “…<div><p>Hypertension is a widespread and life-threatening condition affecting one-third of adults globally. …”
  11. 211

    KAP assessment scores (n = 422). by Chikondi Maluwa (20660522)

    Published 2025
    “…<div><p>Hypertension is a widespread and life-threatening condition affecting one-third of adults globally. …”
  12. 212
  13. 213

    Flow chart for inclusion and exclusion criteria. by Maleda Tefera (9025154)

    Published 2025
    “…Children breastfed into their third year of life were more likely to experience underweight and stunting, while breastfeeding during this period was associated with a lower likelihood of wasting.…”
  14. 214
  15. 215
  16. 216
  17. 217

    Sampling process. by Mahée Gilbert-Ouimet (3665080)

    Published 2024
    “…For men patients, direct medical costs were $5351 [4649, 6053] and $4234 [2880, 5588] for women in the first year after the event, $221 [–229, 671] for men and $226 [–727, 1179] for women in the second year, and $11 [–356, 377] for men and $-24 [–612, 564] for women in the third year. This decrease was observed for both men and women, with higher costs for men. …”
  18. 218
  19. 219
  20. 220

    Engineering an Electrospun Composite Ureteral Stent Based on PLGA with Antibacterial Properties and Tailored Mechanical Strength by Halah Hadi Salih (20758553)

    Published 2025
    “…Mono/three-layer electrospun mats were prepared from pure PLGA and PLGA/LDH (3% LDH) with different fiber orientations to control the usual shrinkage of PLGA mats. A third composite with LDH and 0.5% chitosan was developed to enhance the antibacterial properties of the mats in synergy with Zn ions of LDH. …”